Kailera Therapeutics, Inc. share price logo

Kailera Therapeutics, Inc.

NASDAQ: KLRA

Small Cap

$13.95

+0.98

(+7.56%)

Live

as on

Kailera Therapeutics, Inc. Stock Performance

as on November 10, 2026 at 6:34 am IST

  • Day's Low

    Day's High

    $13.01
    $14.33
    downward going graph

    6.74%

    Downside

    2.72%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Kailera Therapeutics, Inc. share price movements today

Previous Close
$12.97
Open
$13.42
Volume
675.5K
Market Cap
$1.7B
Day's Low - High
$13.01 - $14.33

Kailera Therapeutics, Inc. Historical Returns

1 Month Return
+ 11.71 %
3 Month Return
-30.49 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Kailera Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Kailera Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-2.5

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.19

Industry PE ratio

-7.60

PEG Ratio

0.04

EBITDA

-369.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-102.35%

Kailera Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kailera Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.7BNA-5.190.00%0.00%
Neutral$101.5B7.32%-35.9528.00%0.00%
StrongBuy$46.5BNA66.6588.39%0.00%
StrongBuy$138.7B186.30%34.9485.57%0.00%
Buy$93.5B46.74%19.2685.77%0.41%

Analyst Recommendation on Kailera Therapeutics, Inc. Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Kailera Therapeutics, Inc.. Average target price of $57

Kailera Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Kailera Therapeutics, Inc..

Current Price

$13.95

Analyzed by

1 Analysts

High

$57

0

Low

$57

Kailera Therapeutics, Inc. target price $0, a slight upside of 0% compared to current price of $13.95. According to 1 analysts rating.

Indian Investors' Interest in Kailera Therapeutics, Inc. Stock

Search interest for Kailera Therapeutics, Inc. Stock has increased by 197% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:197% versus previous 30 day period

Kailera Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-67
-84
-121
-106
EBITDA
-67
-84
-111
-106
Interest Expense
-
-
-
-
Depreciation
0
0
0
0
Income Before Tax
-62
-78
-111
-95
Income Tax Expense
-
-
-
-
Net Income
-62
-78
-111
-95
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Kailera Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2025
Total Revenue
-
Gross Profit
-
Operating Income
-158
EBITDA
-158
Interest Expense
-
Depreciation
0
Income Before Tax
-148
Income Tax Expense
-
Net Income
-148
Net Profit Margin
0.00%

Kailera Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-62
-78
-111
-95
Operating Cash Flow
-46
-68
-77
-133
Investing Cash Flow
-390
22
-571
110
Financing Cash Flow
498
-2
667
0
Change in Cash
62
-48
18
-23

Kailera Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-148
Operating Cash Flow
-120
Investing Cash Flow
-492
Financing Cash Flow
598
Change in Cash
-14

Global Institutional Holdings in Kailera Therapeutics, Inc.

Check out the Institutions with significant holdings in Kailera Therapeutics, Inc..

Funds
Holdings
Bain Capital Investors Llc
20.22%
Andrew T. Kaplan
20.22%
Bain Capital Life Sciences Investors, LLC
17.39%
Adam Koppel
17.39%
RTW INVESTMENTS, LP
8.30%

Insights on Kailera Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, KLRA stock has moved up by 6.7%

About Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights for global development and commercialization of four metabolic disease assets outside of Greater China, with therapies delivered through oral and injectable formulations. The company was founded in 2024 and is based in Waltham, Massachusetts.
OrganisationKailera Therapeutics, Inc.
Headquarters180 Third Avenue, 4th Floor, Waltham, MA, 02451, US
IndustryBiotechnology
CEORonald C. Renaud Jr.

Key Management of Kailera Therapeutics, Inc.

Name

Title

Mr. Paul Douglas Burgess J.D., M.S.

Chief Operating & Business Officer

Ms. Jamie Beth Coleman

Chief Commercial Officer

Maura Gavaghan

Vice President of Corporate Communications & Investor Relations

Ms. Paula A. Cloghessy SHRM-SCP, SPHR

Chief People Officer

Ms. Kathleen Tregoning M.A.

Chief Corporate Affairs Officer

Mr. Ronald C. Renaud Jr., M.B.A.

President, CEO & Director

Mr. Scott M. Akamine J.D.

Chief Legal Officer & Secretary

Dr. Scott M. Wasserman M.D.

Chief Medical Officer

Mr. Corey Manchester

Treasurer

Mr. Douglas W. Pagan M.B.A.

Chief Financial Officer

FAQs

What is Kailera Therapeutics, Inc. share price today?

Kailera Therapeutics, Inc. share price today is $13.95 as on . Kailera Therapeutics, Inc. share today touched a day high of $14.33 and a low of $13.01.

What is the 52 week high and 52 week low for Kailera Therapeutics, Inc. share?

Kailera Therapeutics, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Kailera Therapeutics, Inc. stock price today i.e. is trending at $13.95,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Kailera Therapeutics, Inc.'s market capitalisation today?

Kailera Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Kailera Therapeutics, Inc. Stock (KLRA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kailera Therapeutics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Kailera Therapeutics, Inc. Stock (KLRA) from India?

Indian investors can start investing in Kailera Therapeutics, Inc. (KLRA) shares with as little as ₹93.92749786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.27 in Kailera Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Kailera Therapeutics, Inc. share’s latest price of $13.95 as on November 10, 2026 at 1:04 am IST, you will get 0.7168 shares of Kailera Therapeutics, Inc.. Learn more about fractional shares .